conformis
Cleveland HeartLab pulls in $15M | Wall Street Beat
Cleveland HeartLab pulled in $14.7 million in equity financing for its proprietary test for cardiac inflammation, according to a regulatory filing.
The CardioMPO test was developed by Dr. Stanley Hazen, director of the Cleveland Clinic’s center for cardiovascular diagnostics and prevention.
Cleveland HeartLab closed a $3 million round in 2010, with backers including Glengary and Second Generation Ltd.
ConforMIS launches next-gen iTotal G2 custom knee implants
Orthopedics devices maker ConforMIS released the latest iteration of its iTotal G2 total knee replacement system, the only such device on the market today, according to the company.
The G2 represents a years’ worth of surgeon feedback on the original design, which the FDA cleared in January 2011 and was released to a limited group of surgeons a few months later, according to a press release.
MassDevice.com +3 | The top 3 med-tech stories for June 14, 2012.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
ConforMIS reports $114M raised since 2011 in latest tally
Orthopedics devices maker ConforMIS is in a fund-raising frenzy, raising $113.8 million since 2011 to develop its custom joint implant technology, according to regulatory filings.
ConforMIS seeks $68 million in new funding round
Orthopedics devices maker ConforMIS launched a $68 million funding round that will close at the end of this month.
ConforMIS is offering equity, securities and options with no minimum investor, according to regulatory filings.
ConforMIS calls out Stanmore Implants on custom knee patents
Burlington, Mass.-based ConforMIS filed documents officially contesting a patent application for a personalized knee replacement system that Stanmore Implants claims to be the world’s 1st.
MassDevice.com Podcast: ConforMis CEO Philipp Lang
Philipp Lang has ConforMIS looking to get a leg up on the knee replacement industry.
Last week, the Burlington, Mass.-based orthopedic implant maker said it raised $89 million in a Series E round from several investors, bringing the total nut raised by ConforMIS over the last 3 years to more than $140 million – a somewhat remarkable amount, given the fundraising climate over the past few years.
Conformis nets $89 million in Series E round
ConforMIS Inc. said it’s closed another massive funding round to support its line of personalized knee implants.
The Burlington, Mass.-based orthopedic device maker said it raised $89 million in a Series E round from several investors, including AGC Equity Partners and Axel Johnson, along with government investment funds from Asia and the UAE.
ConforMIS has now raised about $140 million since 2009.
Mahmoud Hafez joins ConforMIS scientific advisory board
BURLINGTON, Mass.–(BUSINESS WIRE)–ConforMIS announced that Prof. Mahmoud Hafez, PhD has joined the ConforMIS SAB. Dr. Hafez is a professor of orthopaedics and the head of the Orthopaedic Department at October 6 University in Cairo.
ConforMIS lands $1.4 million MassDevelopment loan | Funding Roundup
ConforMIS Inc. is on a roll the announcement that it secured a $1.4 million loan from MassDevelopment’s Emerging Technology Fund.
The loan will go toward growing the Burlington, Mass.-based company’s supply chain and manufacturing capacity for its iTotal customized knee replacement system.